1069 related articles for article (PubMed ID: 19249508)
21. [Renal transplantation in patients with autosomal dominant polycystic kidney disease: pre-transplantation evaluation and follow-up].
Bretagnol A; Büchler M; Boutin JM; Nivet H; Lebranchu Y; Chauveau D
Nephrol Ther; 2007 Dec; 3(7):449-55. PubMed ID: 18047999
[TBL] [Abstract][Full Text] [Related]
22. Complications of autosomal dominant polycystic kidney disease in 50 haemodialysed patients. A case-control study. The U.C.L. Collaborative Group.
Christophe JL; van Ypersele de Strihou C; Pirson Y
Nephrol Dial Transplant; 1996 Jul; 11(7):1271-6. PubMed ID: 8672022
[TBL] [Abstract][Full Text] [Related]
23. Management of ESRD in patients with autosomal dominant polycystic kidney disease.
Alam A; Perrone RD
Adv Chronic Kidney Dis; 2010 Mar; 17(2):164-72. PubMed ID: 20219619
[TBL] [Abstract][Full Text] [Related]
24. Hypertension in autosomal dominant polycystic kidney disease: observational study in 207 patients with a mean follow-up of 107 months.
De Almeida EA; Prata MM
Rev Port Cardiol; 2007 Nov; 26(11):1173-82. PubMed ID: 18297839
[TBL] [Abstract][Full Text] [Related]
25. Transplantation of a cadaveric polycystic kidney in a patient with autosomal dominant polycystic kidney disease: long-term outcome.
Powell CR; Tata S; Govani MV; Chien GW; Orvieto MA; Shalhav AL
Transplant Proc; 2004 Jun; 36(5):1288-92. PubMed ID: 15251314
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous transabdominal bilateral nephrectomy in potential kidney transplant recipients.
Król R; Ziaja J; Cierniak T; Pawlicki J; Chudek J; Wiecek A; Cierpka L
Transplant Proc; 2006; 38(1):28-30. PubMed ID: 16504655
[TBL] [Abstract][Full Text] [Related]
27. Outcome of kidney transplantation in patients with polycystic kidney disease: a single center study.
Roozbeh J; Razmkon AR; Jalaeian H; Raiss-Jalali GA; Behzadi S; Sagheb MM; Salahi H; Bahador A; Nikeghbalian S; Davari HR; Salehipour M; Malek-Hosseini SA
Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):72-5. PubMed ID: 18087127
[TBL] [Abstract][Full Text] [Related]
28. Mammalian target of rapamycin and autosomal dominant polycystic kidney disease.
Wüthrich RP; Serra AL
Transplant Proc; 2009; 41(6 Suppl):S18-20. PubMed ID: 19651290
[TBL] [Abstract][Full Text] [Related]
29. Staged nephrectomy versus bilateral laparoscopic nephrectomy in patients with autosomal dominant polycystic kidney disease.
Lucas SM; Mofunanya TC; Goggins WC; Sundaram CP
J Urol; 2010 Nov; 184(5):2054-9. PubMed ID: 20850813
[TBL] [Abstract][Full Text] [Related]
30. Carbohydrate antigen 19-9 as a diagnostic marker for hepatic cyst infection in autosomal dominant polycystic kidney disease.
Kanaan N; Goffin E; Pirson Y; Devuyst O; Hassoun Z
Am J Kidney Dis; 2010 May; 55(5):916-22. PubMed ID: 20189277
[TBL] [Abstract][Full Text] [Related]
31. Transplantation in autosomal dominant polycystic kidney disease without nephrectomy.
Knispel HH; Klän R; Offermann G; Miller K
Urol Int; 1996; 56(2):75-8. PubMed ID: 8659014
[TBL] [Abstract][Full Text] [Related]
32. Autosomal dominant polycystic kidney disease: MR imaging evaluation using current techniques.
Mosetti MA; Leonardou P; Motohara T; Kanematsu M; Armao D; Semelka RC
J Magn Reson Imaging; 2003 Aug; 18(2):210-5. PubMed ID: 12884334
[TBL] [Abstract][Full Text] [Related]
33. Retrospective analysis of factors affecting the progression of chronic renal failure in adult polycystic kidney disease.
Ahmed ER; Tashkandi MA; Nahrir S; Maulana A
Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):511-5. PubMed ID: 17186685
[TBL] [Abstract][Full Text] [Related]
34. Laparoscopic bilateral native nephrectomies with simultaneous kidney transplantation.
Martin AD; Mekeel KL; Castle EP; Vaish SS; Martin GL; Moss AA; Mulligan DC; Heilman RL; Reddy KS; Andrews PE
BJU Int; 2012 Dec; 110(11 Pt C):E1003-7. PubMed ID: 22882539
[TBL] [Abstract][Full Text] [Related]
35. [Results of nephrectomy in patients with autosomal dominant polycystic kidney disease].
López-Corona E; García-González VM; Gabilondo F
Rev Invest Clin; 2004; 56(4):437-42. PubMed ID: 15587288
[TBL] [Abstract][Full Text] [Related]
36. End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantation.
Fuller TF; Brennan TV; Feng S; Kang SM; Stock PG; Freise CE
J Urol; 2005 Dec; 174(6):2284-8. PubMed ID: 16280813
[TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.
Bae KT; Zhu F; Chapman AB; Torres VE; Grantham JJ; Guay-Woodford LM; Baumgarten DA; King BF; Wetzel LH; Kenney PJ; Brummer ME; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
Clin J Am Soc Nephrol; 2006 Jan; 1(1):64-9. PubMed ID: 17699192
[TBL] [Abstract][Full Text] [Related]
38. Retroperitoneoscopic nephrectomy as a second-line treatment after transarterial embolization for symptomatic autosomal dominant polycystic kidney disease.
Akamatsu S; Kinoshita H; Shimizu Y; Yoshimura K; Ito N; Kamoto T; Ogawa O
Hinyokika Kiyo; 2006 Dec; 52(12):947-50. PubMed ID: 17252979
[TBL] [Abstract][Full Text] [Related]
39. Retroperitoneoscopic nephrectomy for autosomal dominant polycystic kidney disease: initial experience.
Wyler SF; Bachmann A; Ruszat R; Forster T; Hudolin T; Gasser TC; Sulser T
Urol Int; 2007; 79(2):137-41. PubMed ID: 17851283
[TBL] [Abstract][Full Text] [Related]
40. Deceased donor kidney transplantation in autosomal dominant polycystic kidney disease: a single-center experience.
Kute VB; Shah PR; Goplani KR; Gumber MR; Vanikar AV; Patel HV; Jain SH; Enginner DP; Trivedi HL
Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):911-6. PubMed ID: 21912018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
